In older Poles, slightly low hemoglobin was linked to higher death risk over ten years

Hemoglobin is the iron-containing protein in red blood cells that carries oxygen from the lungs to the rest of the body. When there is too little of it, a person has anemia. In older people, mild anemia is common, and doctors have long debated whether it matters much: some have called it an "innocent bystander" of aging, and some have even suggested lowering the normal range for older adults.

A team from Polish universities, using data from the nationwide PolSenior project, asked a direct question: at what hemoglobin level does the risk of death start to climb, and does that link hold up once other illnesses are accounted for?

What they did

Between 2007 and 2012, PolSenior examined older adults living at home across Poland. This analysis included 3,806 people aged 65 to 103, 1,811 women and 1,995 men, who had a blood count and had no cancer and were not on dialysis. Each went through a broad geriatric check: basic and more complex everyday activities, falls, walking 200 meters, memory and mood, nutrition, chronic diseases, medicines, and two blood markers of inflammation, the body's alarm response (IL-6 and CRP).

In 2022 the researchers looked up who had died in the national population register. They split people into groups by hemoglobin in steps of 1 g/dL (grams per decilitre of blood), separately for women and men, and used survival models to see whether low hemoglobin still predicted death after adjusting for the other factors. Because kidney disease both causes anemia and raises the risk of death, the analyses were split by kidney function and by age (under or over 80).

What they found

• Over about 9.4 years, 2,167 people (56.9%) died: 49.4% of women and 63.7% of men.
• Those who died had started with lower hemoglobin: on average 13.0 versus 13.4 g/dL in women, and 13.7 versus 14.6 g/dL in men.
• The lowest death rates were in women with 14.0–14.9 g/dL and men with 15.0–15.9 g/dL. Women below 13 g/dL and men below 14 g/dL died more often over time. In women, the highest group (15 g/dL or more) also had somewhat higher mortality, so the curve was not a straight line.
• The team calculated cut-offs below which the risk rose: 13.3 g/dL for women and 13.9 g/dL for men. These sit close to, or even within, what is usually considered a normal range.
• In the adjusted models, low hemoglobin remained linked to higher 5- and 10-year death risk in both sexes, alongside heart failure, memory problems, dementia, difficulty walking 200 meters and needing help with daily tasks. The exact hazard ratios are in the paper's tables.
• People below the cut-offs were also older and more often had malnutrition, heart failure, kidney disease, dementia, depression, falls and dependence on others at the start of the study.

What to keep in mind

• This is an observational study. The authors themselves note that it cannot show that low hemoglobin causes earlier death; it may partly mark illnesses that the adjustments did not fully capture.
• Hemoglobin was measured once, between 2007 and 2012. The team could not follow later changes, treatments such as iron or transfusions, or shifts in health during the ten years.
• The cut-offs predicted death only weakly: they classified people correctly about 58% (women) and 60% (men) of the time. A single hemoglobin number says little about one person's outlook.
• The links with dementia, depression, falls and dependence were seen at the start of the study, at the same time as the blood test, so they show what goes together, not what comes first.
• The study did not test whether raising hemoglobin changes anything. Anemia has many causes, and finding and treating them is a medical question for a doctor, not something this paper answers.
• The data come from Poland only.

Why it matters

Mild anemia in old age is easy to shrug off. This study adds a large, ten-year, nationwide data set to earlier findings that even modest drops in hemoglobin go along with worse survival and loss of independence. The authors argue against lowering hemoglobin reference values for older adults and call for routine screening. Whether acting on these thresholds would actually help people live longer or more independently is something only trials could show.